About Genevia Technologies
Genevia Technologies is a Healthcare company based in Tampere (Finland) founded in 2011. Full-service bioinformatics support is provided for research and industries. Genevia Technologies offers products and services including DNA-seq Data Analysis, RNA-seq Data Analysis, Single-cell RNA-seq Data Analysis, Spatial Transcriptomic Data Analysis, and Epigenomic Data Analysis. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis. Its legal entity is Genevia Technologies Oy.
Company details
Genevia Technologies was founded in 2011 in Tampere, Finland, where operations in the bioinformatics sector are centered. Complete omics analyses are delivered to biopharma companies, research institutions, and diagnostics firms through full-service support. Analysis software is also supplied to automate pipeline analyses and workflows, aiding efficiency in research and industrial applications. The domain geneviatechnologies.com is utilized for online presence.
- Headquarters Tampere, Finland
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website geneviatechnologies.com
- Social LinkedIn X Instagram
- Legal Name Genevia Technologies Oy
- Investors
Products & Services of Genevia Technologies
Genevia Technologies offers a comprehensive portfolio of products and services, including DNA-seq Data Analysis, RNA-seq Data Analysis, Single-cell RNA-seq Data Analysis, Spatial Transcriptomic Data Analysis, and Epigenomic Data Analysis.
Analyzes DNA sequencing data for mutations and genetic variation.
Performs transcriptome-wide expression analysis for biological systems.
Catalogs cells using single-cell sequencing for detailed resolution.
Examines molecular organization in complex tissues spatially.
Analyzes chromatin modifications for gene regulation insights.
Funding Insights of Genevia Technologies
- Total Rounds 2
- First Round $319,447
(Mar 2019)
- Investors Count 1
All 2 funding rounds of Genevia Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2019 | Grant | – | – | ||
| Mar 2019 | $319,447 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Genevia Technologies
Genevia Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Genevia Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genevia Technologies
3 dated milestones of Genevia Technologies across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Genevia Technologies is founded.
- Funding First funding round of $319K.
- Funding Latest funding round, Grant,.
Web traffic of Genevia Technologies
The website of Genevia Technologies (geneviatechnologies.com) receives about 7.3K visits a month.
- Monthly visits7.3K
▼ 24.4% vs previous month
Websites whose visitors overlap most with Genevia Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioinformaticscro.com | 100% | #3,096,928 | View details | ||
bioinformaticsworkbook.org | bioinformaticsworkbook.org | 97% | #1,328,759 | – | |
| genecopoeia.com | 94% | 17.2K | #1,512,108 | View details | |
| lexogen.com | 92% | 16.5K | #1,659,114 | View details | |
| rna-seqblog.com | 84% | #669,184 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genevia Technologies
Genevia Technologies was founded in 2011 and raised its 1st funding round 8 years after it was founded.
Genevia Technologies is headquartered in Tampere, Finland.
Genevia Technologies was founded in 2011 in Tampere, Finland, where operations in the bioinformatics sector are centered. Complete omics analyses are delivered to biopharma companies, research institutions, and diagnostics firms through full-service support. Analysis software is also supplied to automate pipeline analyses and workflows, aiding efficiency in research and industrial applications. The domain geneviatechnologies.com is utilized for online presence.
Genevia Technologies offers DNA-seq Data Analysis, RNA-seq Data Analysis, Single-cell RNA-seq Data Analysis, Spatial Transcriptomic Data Analysis, and Epigenomic Data Analysis.
Genevia Technologies has 1 investor. Key investors include European Union.
Genevia Technologies operates through Genevia Technologies Oy.